Petmed Express Inc
PETS Nasdaq· Retail-Drug Stores And Proprietary Stores
Last close · Oct 27, 2026
$1.18
KIRA · Stoqly’s AI analyst, in plain words
- Petmed Express Inc had $179M of revenue in fiscal 2026, down 21.1% on the year before. Over five years, revenue changed −10.0% a year on average.
- Its operating margin was −32.8%, down 32.1 pts: of every 100 in sales, about −33 is left after running the business.
- Petmed Express Inc lost $57.3M in fiscal 2026.
- Free cash flow was −$33.0M in fiscal 2026, −18.4% of revenue.
- Petmed Express Inc returned $0.0M to shareholders in fiscal 2026. The diluted share count rose 1.6%.
Market cap
$25.6M
P/E
—
Revenue
$179M
Net income
−$57.3M
Free cash flow
−$33.0M
Operating margin
−32.8%
Petmed Express Inc in 30 seconds · fiscal 2026
Are sales growing?
−21.1%
No. Sales fell 21.1% last year.
Does it make a profit?
−32.0%
No. It lost money last year.
Does profit turn into cash?
−18.4%
No. It spent more cash than it brought in.
How healthy are the accounts?
2 / 8
Weak. It passes 2 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Petmed Express Inc does
No business description yet.
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 10-K · Jun 2, 2026
- Legal name
- PETMED EXPRESS INC
- CIK
- 0001040130
Petmed Express Inc · PETS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $272M | $248M | $274M | $227M | $179M |
| Revenue growth | −10.3% | −9.1% | 10.7% | −17.2% | −21.1% |
| Gross margin | 28.3% | 30.9% | 30.9% | 30.5% | 28.1% |
| Operating margin | 8.9% | 2.4% | −3.0% | −0.7% | −32.8% |
| Net income | $18.7M | $5.1M | −$7.5M | −$6.3M | −$57.3M |
| Net margin | 6.9% | 2.1% | −2.7% | −2.8% | −32.0% |
| Diluted EPS | $0.92 | $0.25 | −$0.37 | −$0.30 | −$2.74 |
| Cash | |||||
| Cash from operations | $18.5M | $27.8M | $4.3M | $4.7M | −$28.4M |
| Capital expenditure | $1.8M | $5.3M | $4.5M | $5.1M | $4.6M |
| Free cash flow | $16.7M | $22.5M | −$0.2M | −$0.4M | −$33.0M |
| FCF margin | 6.2% | 9.1% | −0.1% | −0.2% | −18.4% |
| Dividends paid | $24.4M | $24.5M | $12.4M | $0.2M | $0.0M |
| Share buybacks | $0.0M | — | — | — | — |
| Share count change | 1.2% | −0.1% | 0.3% | 1.0% | 1.6% |
| Debt and strength | |||||
| Cash and short-term investments | $111M | $104M | $55.3M | $54.7M | $21.4M |
| Shareholders' equity | $123M | $110M | $96.7M | $85.1M | $28.9M |
| Current ratio | 2.7x | 2.3x | 1.3x | 1.3x | 0.8x |
| Returns and quality | |||||
| Return on equity | 15.1% | 4.4% | −7.2% | −6.9% | −100.4% |
| Return on tangible equity | 15.3% | 4.7% | −12.7% | −12.4% | −244.3% |
| Piotroski F-score | 3 | 5 | 4 | 3 | 2 |
| Altman Z'' | 8.7 | 6.9 | 3.3 | 3.5 | −4.6 |
Insiders bought, 12 months
$0.0M
1 insider
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Petmed Express Inc · PETS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.18 a share, the company is worth $25.6M.
Source: SEC EDGAR XBRL filings (CIK 0001040130). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.